---
reference_id: "PMID:32601469"
title: Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis.
authors:
- Park YH
- Remmers EF
- Lee W
- Ombrello AK
- Chung LK
- Shilei Z
- Stone DL
- Ivanov MI
- Loeven NA
- Barron KS
- Hoffmann P
- Nehrebecky M
- Akkaya-Ulum YZ
- Sag E
- Balci-Peynircioglu B
- Aksentijevich I
- Gül A
- Rotimi CN
- Chen H
- Bliska JB
- Ozen S
- Kastner DL
- Shriner D
- Chae JJ
journal: Nat Immunol
year: '2020'
doi: 10.1038/s41590-020-0705-6
content_type: abstract_only
---

# Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis.
**Authors:** Park YH, Remmers EF, Lee W, Ombrello AK, Chung LK, Shilei Z, Stone DL, Ivanov MI, Loeven NA, Barron KS, Hoffmann P, Nehrebecky M, Akkaya-Ulum YZ, Sag E, Balci-Peynircioglu B, Aksentijevich I, Gül A, Rotimi CN, Chen H, Bliska JB, Ozen S, Kastner DL, Shriner D, Chae JJ
**Journal:** Nat Immunol (2020)
**DOI:** [10.1038/s41590-020-0705-6](https://doi.org/10.1038/s41590-020-0705-6)

## Content

1. Nat Immunol. 2020 Aug;21(8):857-867. doi: 10.1038/s41590-020-0705-6. Epub 2020
 Jun 29.

Ancient familial Mediterranean fever mutations in human pyrin and resistance to 
Yersinia pestis.

Park YH(#)(1)(2), Remmers EF(#)(1), Lee W(1), Ombrello AK(1), Chung LK(3), 
Shilei Z(4)(5)(6), Stone DL(1), Ivanov MI(3), Loeven NA(3)(7), Barron KS(8), 
Hoffmann P(1), Nehrebecky M(1), Akkaya-Ulum YZ(9), Sag E(10), Balci-Peynircioglu 
B(9), Aksentijevich I(1), Gül A(11), Rotimi CN(12), Chen H(4)(5)(6), Bliska 
JB(3)(7), Ozen S(10), Kastner DL(13), Shriner D(12), Chae JJ(14).

Author information:
(1)Inflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory 
Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, 
USA.
(2)Center for Genomic Integrity, Institute for Basic Science, Ulsan, Republic of 
Korea.
(3)Department of Molecular Genetics and Microbiology, School of Medicine, Stony 
Brook University, Stony Brook, NY, USA.
(4)Beijing Institute of Genomics, Chinese Academy of Sciences and China National 
Center for Bioinformation, Beijing, China.
(5)University of Chinese Academy of Sciences, Beijing, China.
(6)Center for Excellence in Animal Evolution and Genetics, Chinese Academy of 
Sciences, Kunming, China.
(7)Department of Microbiology and Immunology, Geisel School of Medicine at 
Dartmouth, Hanover, NH, USA.
(8)Division of Intramural Research, National Institute of Allergy and Infectious 
Diseases, Bethesda, MD, USA.
(9)Department of Medical Biology, Hacettepe University Faculty of Medicine, 
Ankara, Turkey.
(10)Department of Pediatrics, Division of Rheumatology, Hacettepe University 
Faculty of Medicine, Ankara, Turkey.
(11)Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty 
of Medicine, Istanbul University, Istanbul, Turkey.
(12)Center for Research on Genomics and Global Health, National Human Genome 
Research Institute, Bethesda, MD, USA.
(13)Inflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory 
Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, 
USA. dan.kastner@nih.gov.
(14)Inflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory 
Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, 
USA. chaej@mail.nih.gov.
(#)Contributed equally

Comment in
    Nat Immunol. 2020 Aug;21(8):833-834. doi: 10.1038/s41590-020-0724-3.
    Nat Rev Immunol. 2020 Aug;20(8):462-463. doi: 10.1038/s41577-020-0395-1.

Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by 
homozygous or compound heterozygous gain-of-function mutations in MEFV, which 
encodes pyrin, an inflammasome protein. Heterozygous carrier frequencies for 
multiple MEFV mutations are high in several Mediterranean populations, 
suggesting that they confer selective advantage. Among 2,313 Turkish people, we 
found extended haplotype homozygosity flanking FMF-associated mutations, 
indicating evolutionarily recent positive selection of FMF-associated mutations. 
Two pathogenic pyrin variants independently arose >1,800 years ago. Mutant pyrin 
interacts less avidly with Yersinia pestis virulence factor YopM than with 
wild-type human pyrin, thereby attenuating YopM-induced interleukin (IL)-1β 
suppression. Relative to healthy controls, leukocytes from patients with FMF 
harboring homozygous or compound heterozygous mutations and from asymptomatic 
heterozygous carriers released heightened IL-1β specifically in response to 
Y. pestis. Y. pestis-infected MefvM680I/M680I FMF knock-in mice exhibited 
IL-1-dependent increased survival relative to wild-type knock-in mice. Thus, FMF 
mutations that were positively selected in Mediterranean populations confer 
heightened resistance to Y. pestis.

DOI: 10.1038/s41590-020-0705-6
PMCID: PMC7381377
PMID: 32601469 [Indexed for MEDLINE]

Conflict of interest statement: COMPETING INTERESTS The authors declare no 
competing interests